Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-Blockade

Journal of the American College of Cardiology

Volumn 57, Issue 5, 2011, Pages 601-611

  Sorrentino, Sajoscha A ^a   Doerries, Carola ^a,b   Manes, Costantina ^a,b   Speer, Thimoteus ^b   Dessy, Chantal ^c   Lobysheva, Irina ^c   Mohmand, Wazma ^a   Akbar, Razma ^a   Bahlmann, Ferdinand ^a   Besler, Christian ^a,b   Schaefer, Arnd ^a   Hilfiker Kleiner, Denise ^a   Lüscher, Thomas F ^b   Balligand, Jean Luc ^c   Drexler, Helmut ^a   Landmesser, Ulf ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

adrenoreceptor blocker; early endothelial progenitor cells; endothelial function; left ventricular remodeling; myocardial infarction

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; METOPROLOL SUCCINATE; NEBIVOLOL; PLACEBO; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE; CAPILLARY DENSITY; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CAPILLARY; HEART MUSCLE CELL; HEART MUSCLE NEOVASCULARIZATION; HEART RATE; HEART VENTRICLE HYPERTROPHY; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SURVIVAL; VASCULAR ENDOTHELIUM; VASODILATATION; WILD TYPE;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; BENZOPYRANS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ETHANOLAMINES; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; RANDOM ALLOCATION; RATS; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79251518319     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.09.037     Document Type: Article

References (48)

1. J. Lopez-Sendon, K. Swedberg, and J. McMurray Expert consensus document on beta-adrenergic receptor blockers Eur Heart J 25 2004 1341 1362
2. M.A. Broeders, P.A. Doevendans, and B.C. Bekkers Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production Circulation 102 2000 677 684
3. J.R. Cockcroft, P.J. Chowienczyk, and S.E. Brett Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism J Pharmacol Exp Ther 274 1995 1067 1071
4. N. Tzemos, P.O. Lim, and T.M. MacDonald Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study Circulation 104 2001 511 514
5. A.A. de Groot, M.J. Mathy, P.A. van Zwieten, and S.L. Peters Involvement of the beta3 adrenoceptor in nebivolol-induced vasorelaxation in the rat aorta J Cardiovasc Pharmacol 42 2003 232 236
6. C. Dessy, S. Moniotte, P. Ghisdal, X. Havaux, P. Noirhomme, and J.L. Balligand Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization Circulation 110 2004 948 954
7. J.L. Balligand beta(3)-adrenoceptor stimulation on top of beta(1)-adrenoceptor blockade: "Stop or encore?" J Am Coll Cardiol 53 2009 1539 1542
8. H.J. Garban, G.M. Buga, and L.J. Ignarro Estrogen receptor-mediated vascular responsiveness to nebivolol: a novel endothelium-related mechanism of therapeutic vasorelaxation J Cardiovasc Pharmacol 43 2004 638 644
9. H. Mollnau, E. Schulz, and A. Daiber Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells Arterioscler Thromb Vasc Biol 23 2003 615 621
10. R.P. Mason, L. Kalinowski, R.F. Jacob, A.M. Jacoby, and T. Malinski Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans Circulation 112 2005 3795 3801
11. R. Troost, E. Schwedhelm, S. Rojczyk, D. Tsikas, and J.C. Frolich Nebivolol decreases systemic oxidative stress in healthy volunteers Br J Clin Pharmacol 50 2000 377 379
12. M. Oelze, A. Daiber, and R.P. Brandes Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats Hypertension 48 2006 677 684
13. S.P. Jones, J.J. Greer, R. van Haperen, D.J. Duncker, R. de Crom, and D.J. Lefer Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice Proc Natl Acad Sci U S A 100 2003 4891 4896
14. U. Landmesser, N. Engberding, and F.H. Bahlmann Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase Circulation 110 2004 1933 1939
15. M. Scherrer-Crosbie, R. Ullrich, and K.D. Bloch Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice Circulation 104 2001 1286 1291
16. C. Doerries, K. Grote, and D. Hilfiker-Kleiner Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction Circ Res 100 2007 894 903
17. Y.H. Looi, D.J. Grieve, and A. Siva Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction Hypertension 51 2008 319 325
18. E. Takimoto, and D.A. Kass Role of oxidative stress in cardiac hypertrophy and remodeling Hypertension 49 2007 241 248
19. S. Janssens, P. Pokreisz, and L. Schoonjans Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction Circ Res 94 2004 1256 1262
20. T. Matsunaga, D.W. Weihrauch, M.C. Moniz, J. Tessmer, D.C. Warltier, and W.M. Chilian Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide Circulation 105 2002 2185 2191
21. G. Kojda, J.B. Laursen, and S. Ramasamy Protein expression, vascular reactivity and soluble guanylate cyclase activity in mice lacking the endothelial cell nitric oxide synthase: contributions of NOS isoforms to blood pressure and heart rate control Cardiovasc Res 42 1999 206 213
22. U. Landmesser, S. Dikalov, and S.R. Price Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension J Clin Invest 111 2003 1201 1209
23. P.L. Huang, Z. Huang, and H. Mashimo Hypertension in mice lacking the gene for endothelial nitric oxide synthase Nature 377 1995 239 242
24. S.A. Sorrentino, F.H. Bahlmann, and C. Besler Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone Circulation 116 2007 163 173
25. G. Giannotti, C. Doerries, and P.S. Mocharla Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction Hypertension 55 2010 1389 1397
26. S.A. Sorrentino, C. Besler, and L. Rohrer Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy Circulation 121 2010 110 122
27. T. Asahara, T. Murohara, and A. Sullivan Isolation of putative progenitor endothelial cells for angiogenesis Science 275 1997 964 967
28. F.H. Bahlmann, K. De Groot, and J.M. Spandau Erythropoietin regulates endothelial progenitor cells Blood 103 2004 921 926
29. D. Hilfiker-Kleiner, K. Kaminski, and E. Podewski A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy Cell 128 2007 589 600
30. K.C. Wollert, R. Studer, and K. Doerfer Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat Circulation 95 1997 1910 1917
31. D. Hilfiker-Kleiner, A. Hilfiker, and K. Kaminski Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart Circulation 112 2005 1470 1477
32. D. Hilfiker-Kleiner, P. Shukla, and G. Klein Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction Circulation 122 2010 145 155
33. A.M. Gerdes, T. Onodera, and T. Tamura New method to evaluate myocyte remodeling from formalin-fixed biopsy and autopsy material J Card Fail 4 1998 343 348
34. S. Spiekermann, U. Landmesser, and S. Dikalov Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation Circulation 107 2003 1383 1389
35. A. Aicher, C. Heeschen, and C. Mildner-Rihm Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells Nat Med 9 2003 1370 1376
36. U. Landmesser, H. Cai, and S. Dikalov Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II Hypertension 40 2002 511 515
37. U. Landmesser, K.C. Wollert, and H. Drexler Potential novel pharmacological therapies for myocardial remodelling Cardiovasc Res 81 2009 519 527
38. C. Dessy, J. Saliez, and P. Ghisdal Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol Circulation 112 2005 1198 1205
39. D. Fraccarollo, J.D. Widder, and P. Galuppo Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction Circulation 118 2008 818 827
40. T. Asahara, H. Masuda, and T. Takahashi Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization Circ Res 85 1999 221 228
41. A. Kawamoto, H.C. Gwon, and H. Iwaguro Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia Circulation 103 2001 634 637
42. S. Kaushal, G.E. Amiel, and K.J. Guleserian Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo Nat Med 7 2001 1035 1040
43. H.J. Cho, N. Lee, and J.Y. Lee Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart J Exp Med 204 2007 3257 3269
44. S. Fazel, M. Cimini, and L. Chen Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines J Clin Invest 116 2006 1865 1877
45. C.H. Yoon, M. Koyanagi, and K. Iekushi Mechanism of improved cardiac function after bone marrow mononuclear cell therapy: role of cardiovascular lineage commitment Circulation 121 2010 2001 2011
46. T. Namba, H. Koike, and K. Murakami Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model Circulation 108 2003 2250 2257
47. A.J. Bank, A.S. Kelly, A.M. Thelen, D.R. Kaiser, and J.M. Gonzalez-Campoy Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus Am J Hypertens 20 2007 777 783
48. J. Heineke, and J.D. Molkentin Regulation of cardiac hypertrophy by intracellular signalling pathways Nat Rev Mol Cell Biol 7 2006 589 600